Skip to main content

Table 1 References for characterization of human TIL

From: Cancer-induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism How Antigenic Tumors Escape Immune-mediated Killing

Human Tumor Type

Presence of TIL

Expression of Activation Markers

TIL Proliferation Defect

TIL Lytic Defect

Breast carcinoma

(98)

(59,99,100)

(59,99,100)

(99,100)

Prostate carcinoma

(101,102)

(57)

(101)

(57)

Lung carcinoma

(103)

(99,100,104)

(99,100,104)

(99,100,104)

Colorectal carcinoma

(85)

(100,105)

(100,105)

(100,105)

Cervical carcinoma

(106,107)

—

(107)

(107)

Leukemia/lymphoma

(108)

—

(101,102)

(109)

Ovarian carcinoma

(110)

(111,112)

(100)

(111,112)

Renal cell carcinoma

(113)

(55)

(55)

(114)

Liver carcinoma

(115–118)

(119)

—

—

Melanoma

(120)

(100)

(100)

(70,121)

Back to article page

Molecular Medicine

ISSN: 1528-3658